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commentaries

Are We Missing the Elephant in the
Room? A Case for Thyroid Cancer
Overdiagnosis As the Etiology for Its
Increasing Incidence in India
The incidence of differentiated thyroid cancers,
especially the papillary subtype, has been increasing
worldwide. The SEER database from the United
States showed a three-fold increase in thyroid
cancer incidence from 1975 to 2010, with a relatively stable thyroid cancer–specific mortality
rate.1 Similarly, in South Korea, thyroid cancer
incidence increased by seven-fold from 1999 to
2009.2 India is not an exception to this trend.3
Several regions of India have seen an increase in
incidence of thyroid cancer.
Women are predominantly affected by this trend.1
The majority of newly diagnosed thyroid cancers
are small and of the papillary histologic type.4,5 In
countries where the incidence is rapidly increasing, the increase has been attributed to a disproportionate increase in diagnosis of small papillary
thyroid cancers.6 Approximately one sixth of com
puted tomography scans and magnetic resonance
images show incidental thyroid nodules, of which
the majority are smaller nodules.7,8
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On the basis of such information, several studies
from developed regions of the world have concluded that overdiagnosis is the leading cause
of this astounding increase in the incidence of
thyroid cancer.9,10 The influence of environmental
and other risk factors on this increased incidence
is controversial and, if present, likely marginal. An
increase in the prevalence of risk factors such as
obesity and tobacco use could contribute to an
increased incidence of thyroid cancer. However,
why are women in India, who have lower rates of
obesity and smoking, also experiencing an increase
in thyroid cancer diagnosis?
We recently reported that overdiagnosis could be
the reason for the doubling of thyroid cancer incidence in the state of Kerala in southern India.3
In this region, the incidence of thyroid cancer
is at least four-fold the incidence seen in other

1

regions of India. In the population-based cancer
registry (PBCR) based in the city of Thiruvananthapuram in Kerala, the incidence of thyroid
cancer doubled over a decade. The age-adjusted
incidence rate in 2005 to 2008 was 6.9 per
100,000 women; this rate increased to 13.3 per
100,000 women in 2012 to 2014. However, the
mortality rate remained stable. Similar trends in
thyroid cancer–specific mortality were also noted
in other PBCRs based in major cities such as
Delhi, Mumbai, Bangalore, and Chennai. It is
this mismatch between the increased incidence
rate and stable mortality rate of thyroid cancer
that points to the contribution of overdiagnosis.
However, a recent editorial in the Indian Journal
of Cancer overlooked the putative role of overdiagnosis in the increasing incidence rate of thyroid cancer in India.11 The editorial suggests that
the rate of larger thyroid cancers has increased
in India and that the thyroid cancer–specific
mortality rate has also increased. To our knowledge, there are no data from India that confirm
an increase in incidence of larger tumors. The
PBCRs of India do not report data on tumor
size or proportion of patients with differentiated
thyroid cancer diagnosis. In addition, available
data suggest that the thyroid cancer–specific
mortality rate is stable in India.
The editorial points to three putative factors
responsible for the increase in thyroid cancer
rates. First, there is a link between radiation
exposure and thyroid cancer. Could the background radiation from the thorium-rich sand in
Kerala be contributing to an increase in thyroid
cancer rates? This is unlikely; exposure to radiation at the level of a nuclear disaster needs to
occur in the region for incidence rates to increase
at such a rapid pace. Second, thyroid autoimmune diseases may elevate an individual’s risk
jgo.org JGO – Journal of Global Oncology
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for differentiated thyroid cancer. However, such
diseases have not been shown to have increased
in incidence over time. Third, could an increase
in iodine exposure through dietary sources be
elevating the risk for thyroid cancer? Once again,
this hypothesis remains just another oft-cited
theory and is unlikely to have contributed to the
dramatic increase in thyroid cancer rates.

underplaying the importance of overdiagnosis
in India could lead to the same situation as that
seen in South Korea, especially as diagnostic
laboratories and imaging modalities increase in
India. In South Korea, widespread national attention and media coverage called for revision of
existing practices, and as a result, a decrease in
incidence rates has been reported.12

Although all of these putative risk factors cannot be ignored, they do not explain the dramatic
increase in incidence of thyroid cancer. Even if
increasing rates of obesity or tobacco exposure
result in an elevated risk for thyroid cancer, the
strength of such an association would have to be
profound to result in such a significant increase
in the incidence rate of thyroid cancer. One other
factor that could possible result in an increase
the incidence rate is poor quality of diagnosis
documentation in the registry in the initial years.
However, even if this was the case, why would
the incidence in Kerala be four times that seen
in Delhi, Mumbai, Chennai, or Bangalore? The
reality of overdiagnosis as the leading cause of
the increase in incidence of thyroid cancer cannot be pushed under the rug.

Overdiagnosis was thought to be a problem specific to developed nations, but with an epidemiologic transition from communicable diseases to
chronic noninfectious diseases, this phenomenon could occur in developing countries also.
Diagnostic laboratories and imaging facilities
are increasing in India. In fact, Kerala, with its
high socioeconomic and educational status, has
health care quality that matches that of a developed region. This may be the only reasonable
explanation for why the thyroid cancer incidence
rate in Kerala is four times that seen in other
parts of India and why it doubled in a decade.

It is important to look at examples from other
regions that have seen similar trends in increasing incidence of thyroid cancer. The implementation of a national cancer screening program
in South Korea led to providers offering thyroid
screening for a low fee and thus an explosion
of new thyroid cancers. Thyroid cancer incidence in Korea increased slowly in the 1990s
and then increased meteorically in 2011 to 15
times that observed in 1993. Ahn and Welch12
clearly caution the rest of the world on the basis
of their experience with thyroid cancer screening in South Korea. Ignoring this warning and
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Why is it important that we identify the reason for
this phenomenon? A large proportion of patients
diagnosed with thyroid cancer are women
younger than 50 years old, and treatment of thyroid cancer could result in an increased risk for
hypertension, heart disease, stroke, nutritional
deficiencies, and osteoporosis.13 To fulfill the vow
that we took when we became doctors to do no
harm, it is imperative that we see the elephant in
the room for what it is. Overdiagnosis could be
the most plausible hypothesis for the dramatic
increase in thyroid cancer in Kerala and several
other regions in India.
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